1530 related articles for article (PubMed ID: 16849753)
41. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
42. Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms.
Budney AJ; Vandrey RG; Hughes JR; Moore BA; Bahrenburg B
Drug Alcohol Depend; 2007 Jan; 86(1):22-9. PubMed ID: 16769180
[TBL] [Abstract][Full Text] [Related]
43. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
Berenstein EG; Ortiz Z
Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
[TBL] [Abstract][Full Text] [Related]
44. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.
Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D
Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456
[TBL] [Abstract][Full Text] [Related]
45. A phase II study of an herbal decoction that includes Astragali radix for cancer-associated anorexia in patients with advanced cancer.
Lee JJ; Lee JJ
Integr Cancer Ther; 2010 Mar; 9(1):24-31. PubMed ID: 20150220
[TBL] [Abstract][Full Text] [Related]
46. [New strategies for tumor-related cachexia].
HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
[No Abstract] [Full Text] [Related]
47. Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users.
Curran HV; Brignell C; Fletcher S; Middleton P; Henry J
Psychopharmacology (Berl); 2002 Oct; 164(1):61-70. PubMed ID: 12373420
[TBL] [Abstract][Full Text] [Related]
48. Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance.
Müller-Vahl KR; Koblenz A; Jöbges M; Kolbe H; Emrich HM; Schneider U
Pharmacopsychiatry; 2001 Jan; 34(1):19-24. PubMed ID: 11229617
[TBL] [Abstract][Full Text] [Related]
49. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
50. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Sallan SE; Zinberg NE; Frei E
N Engl J Med; 1975 Oct; 293(16):795-7. PubMed ID: 1099449
[TBL] [Abstract][Full Text] [Related]
51. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.
Garcia JM; Polvino WJ
Oncologist; 2007 May; 12(5):594-600. PubMed ID: 17522248
[TBL] [Abstract][Full Text] [Related]
52. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
53. Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial.
De Conno F; Martini C; Zecca E; Balzarini A; Venturino P; Groff L; Caraceni A
Eur J Cancer; 1998 Oct; 34(11):1705-9. PubMed ID: 9893656
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial.
Grube B; Grünwald J; Krug L; Staiger C
Phytomedicine; 2007 Jan; 14(1):2-10. PubMed ID: 17169543
[TBL] [Abstract][Full Text] [Related]
55. The cancer cachexia syndrome.
Puccio M; Nathanson L
Semin Oncol; 1997 Jun; 24(3):277-87. PubMed ID: 9208884
[TBL] [Abstract][Full Text] [Related]
56. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
57. Effects of medroxyprogesterone acetate on food intake, body composition, and resting energy expenditure in patients with advanced, nonhormone-sensitive cancer: a randomized, placebo-controlled trial.
Simons JP; Schols AM; Hoefnagels JM; Westerterp KR; ten Velde GP; Wouters EF
Cancer; 1998 Feb; 82(3):553-60. PubMed ID: 9452274
[TBL] [Abstract][Full Text] [Related]
58. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy.
Kozelsky TF; Meyers GE; Sloan JA; Shanahan TG; Dick SJ; Moore RL; Engeler GP; Frank AR; McKone TK; Urias RE; Pilepich MV; Novotny PJ; Martenson JA;
J Clin Oncol; 2003 May; 21(9):1669-74. PubMed ID: 12721240
[TBL] [Abstract][Full Text] [Related]
59. Usage of megestrol acetate in the treatment of anorexia-cachexia syndrome in the elderly.
Yeh SS; Lovitt S; Schuster MW
J Nutr Health Aging; 2009 May; 13(5):448-54. PubMed ID: 19390752
[TBL] [Abstract][Full Text] [Related]
60. [The effect of blocking TNF-alpha in patients with cancer-related cachexia and anorexia].
Gueta I; Altman A; Shoenfeld Y
Harefuah; 2010 Aug; 149(8):512-4, 551, 550. PubMed ID: 21341430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]